Transcript Exploration of Possible Interest in a Cholesterol

The Use of Oral Anticoagulant
Medications:
Survey of Physicians: Key Findings
Prepared for:
The National Consumers League
September 20, 2005
J23716
Table of Contents
Background & Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Sample and Methodology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Key Findings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Respondent Profile . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
2
Background and Objectives: Physicians
• The physicians survey is the final phase of a
research project designed to inform the
development of an outpatient medication
safety campaign aimed at consumers,
caregivers, and physicians. The physician
survey was designed to gain insight into the
physician’s point of view about issues around
the use and management of oral
anticoagulant medication.
3
Background and Objectives, continued
• Specific areas of inquiry include:
– Treatment and counseling of patients on oral
anticoagulants.
– Patient experiences with oral anticoagulant regimen.
– Ongoing treatment and monitoring patients
4
Sample and Methodology
• This survey was conducted online within the United
States with members of the Harris Interactive
Physician Panel.
• Interviews were conducted between August 11, 2005
and August 18, 2005.
• A total of 101 physicians were interviewed.
– Eligible respondents were practicing medicine in the U.S.:
• Primary care providers (specializing in family practice, internal
medicine or general medicine) and cardiovascular specialists;
• Practicing for at least 5 years and spending at least 70% of
their time in direct patient care;
• Treating 5 or more patients who are on an oral anticoagulant
medication.
• Eligible received received an honorarium of $50 for
completing the survey.
5
Summary of Key Findings
6
Summary of Key Findings: Physicians
1.
2.
3.
4.
5.
Managing patients on anticoagulant medication is a challenge for
physicians.
Most physicians feel that the effort to manage multiple conditions and
medications is the main reason why oral anticoagulant patients
experience difficulties with their regimen.
There is room for improvement in communication by physicians about
oral anticoagulant regimen requirements and blood test results.
Physicians could be doing more to help their patients with ongoing
management of their oral anticoagulant regimen.
Improving blood testing, communication, and involvement with health
care professionals are seen as key components in helping patients
comply with their oral anticoagulant regimen.
7
Case Study
• We asked physicians to tell us about their most
recent visit with a patient on oral anticoagulant
medication.
• This review gives us a glimpse into both the
“average” patient on anticoagulant medication and
the important exceptions.
• It also gives us insight into what physicians are
routinely doing to help manage their anticoagulant
patients.
• We will first present findings from this case study,
focusing both on the average patient and the crucial
exceptions.
• We will then elaborate on key findings, which are
illustrated by this case study.
8
Case Study: Gender and Age
Most anticoagulant patients
are male, but many are
female.
The average anticoagulant
patient is 64 years old.
Less than
35 years
Male
60%
35-44
Female
40%
45-54
2%
6%
19%
65-74
75 or older
30%
26%
Q505
For the next few questions, we would like you to think about the most recent visit that involved a patient who is taking an anticoagulant
medication. Is this patient…?
Base: Qualified Respondents (n=101)
Q511 Approximately how old is the patient?
Base: Qualified Respondents (n=101)
9
Case Study: Primary Condition
55%
Atrial fibrillation
Blood clot, thromboembolism, or
pulmonary embolism
26%
9%
Heart valve replacement
Peripheral vascular disease
2%
Heart failure
2%
Stroke or stroke-like symptoms
A high red blood cell count (polycythemia)
Trans-ischemic attack (TIA)
Other
The average patient is
taking an oral anticoagulant
for atrial fibrillation.
1%
1%
0%
4%
Q510 What is the primary condition for which this patient was prescribed an anticoagulant medication?
Base: Qualified Respondents (n=101)
10
Case Study: Type of Oral Anticoagulant
Medication
The anticoagulants most often taken are
Coumadin or Jantoven and Warfarin.
57%
40%
Coumadin or
Jantoven
Warfarin
1%
1%
0%
1%
Dicumarol
Sintrom or
Acenocoumarol
Miradon or
Anisidione
None of these
Q520 Please indicate the name of the patient’s anticoagulant medication.
Base: Qualified Respondents (n=101)
11
Case Study: Length of Time on Medication
First time
prescribed
6%
Less than 3
months
15%
3 – 6 months
7 - 11 months
16%
8%
1 – 2 years
15%
3 – 4 years
5 years or more
Typical anticoagulant
patients are in all
stages of treatment
longevity. More than
half have been taking
the medication for a
year or longer.
29%
56%
12%
Q515 For approximately how long has this patient been taking the oral anticoagulant ?
Base: Qualified Respondents (n=101)
12
Case Study: Length of Treatment
5%
Less than 6 months
9%
7 - 11 months
3%
1 - 3 years
81%
A lifetime
Not sure
The large majority of
these patients will be
taking an oral
anticoagulant for the
rest of their lives.
2%
Q517 In your opinion, for how long will the patient need to remain on this therapy?
Base: Qualified Respondents (n=101)
13
Case Study: Frequency of Physician Visits
Within the last
week
13%
Within the last 2
weeks
11%
57%
Within the last
month
33%
Within the last 3
months
26%
3 – 6 months ago
Over 6 months
ago
First visit
Q525
13%
1%
More than half of
anticoagulant patients
have been to see their
doctor more than once
in the last month.
3%
Prior to this visit, how long ago was this patient’s last visit?
Base: Qualified Respondents (n=101)
14
Case Study: Reason for Recent Visit
Most doctor visits are for routine care, but visits in reaction to
a problem are not uncommon.
Visit was for
routine care
74%
Q526
Visit was
response to
event or problem
26%
Was this patient’s most recent visit for routine care or related to an event or some type of problem he/she was having?
Base: Qualified Respondents (n=101)
15
Case Study: Communication During Physician Visit
While physicians are doing well with reviewing medication
during patients’ visits, many patients are not being asked
about compliance, problems they may be having, and diet.
Yes
%
No
%
Not sure
%
Review the patient’s latest blood test results
96
4
-
Review all of the patient’s medications, including over-thecounter medications, vitamins and supplements
84
14
2
Ask the patient whether he/she is taking the oral anticoagulant
as prescribed
83
17
-
Ask the patient whether he/she is having any problems related
to taking the oral anticoagulant
79
20
1
Ask the patient about his/her diet
50
49
1
On this patient’s most recent visit did you…?
Q529
Base:
On this patient’s most recent visit did you…?
Qualified respondents (n=101)
16
Case Study: Number of Physician Visits
in Past 12 Months
The average anticoagulant patient visits the doctor 7 times a year.
1
2%
2
11%
3
19%
4
16%
5
16%
6
15%
7
5%
8
5%
9
0%
10
11
12
More than 12
Q531
888.
5%
1%
6%
8%
Not sure: 2%
How many times have you seen this patient in the past year? If you are not sure, your best estimate will do. If you don’t know, please enter
Base: Qualified Respondents (n=101)
17
Case Study: Compliance with Medication
Regimen
The large majority of patients take their anticoagulant
medication as prescribed.
Yes
92%
No
3%
Not sure
5%
% of physicians reporting that patient is taking medication as prescribed
Q540
To the best of your knowledge, is this patient taking his/her anticoagulant medication as prescribed?
Base: Qualified Respondents (n=101)
18
Case Study: Compliance with Blood
Testing
Never
Sometimes
1%
48%
2%
Most of the time
46%
48%
Always
Too early to tell
Have not made any
recommendations
3%
1%
About half of patients could use improvement in
compliance with their doctor’s recommendations
for blood testing.
Q545 Does this patient follow your recommendations to have his/her blood tested regularly?
Base: Qualified Respondents (n=101)
19
Case Study: INR in Desired Range
1 in 4 patients INR is not consistently in the desired range.
No
25%
Too early to tell
11%
Yes
62%
Not sure
2%
% of physicians reporting that patient’s INR is consistently in the desired range
Q550
Is this patient’s INR consistently in the desired range?
Base: Qualified Respondents (n=101)
20
Case Study: Patient’s Management of Oral
Anticoagulant Regimen
Almost half of patients are managing their anticoagulant regimen
less than very well.
Extremely well
19%
Very well
33%
Fairly well
31%
Somewhat well
Not at all well
Not sure
15%
48%
2%
1%
% of physicians indicating how well the patient is managing oral anticoagulant use
Q555 Overall, how well do you think this patient is managing his/her oral anticoagulant?
Base: Qualified Respondents (n=101)
21
Case Study: Ease in Following Treatment
Recommendations
1 in 4 patients have a very or somewhat difficult time following their
doctor’s recommendations related to their anticoagulant regimen.
Very easy
29%
Somewhat easy
45%
Somewhat
difficult
Very difficult
Not sure
24%
2%
26%
1%
% of physicians indicating how difficult it is for the patient to follow all of their recommendations
Q560 To the best of your knowledge, how easy or difficult is it for this patient to follow all of your recommendations related to taking his/her oral
anticoagulant?
Base: Qualified Respondents (n=101)
22
Case Study: Caregivers
45% of patients have a caregiver assisting with their medication
management. For 1 in 10 patients, the physician does not know if
a caregiver is involved.
No
45%
Yes
45%
Not Sure
11%
% of physicians who say that patient has assistance in anticoagulant management
Q565 To the best of your knowledge, does this person have a family member or other caregiver who is actively involved in assisting with his/her
oral anticoagulation management?
Base: Qualified Respondents (n=101)
23
Key Finding #1: Managing patients on anticoagulant
medication is a challenge for physicians.
•
•
•
•
•
Compared to other chronically ill patients, oral anticoagulant
patients require more time spent adjusting medication, reviewing
and relaying test results and other consultations.
Two in five patients suffered a significant life-threatening event
that precipitated treatment with blood thinning medication.
Side effects or problems due to oral anticoagulant use are not
uncommon. Majorities of physicians report that their oral
anticoagulant patients have had problems due to their
anticoagulant medication. In general patients called and/or visited
the physician’s office, however, more than half of physicians
report the their patients went to the emergency room and/or the
hospital as a result of these complications.
Physicians frequently have to make adjustments in dosage and
counsel patients about guidelines because of problems related to
their oral anticoagulant use.
Physicians see patient non-compliance with their medication and
blood testing regimen as the biggest challenges they face in
managing these patients.
24
Chart 1: Anticoagulant patients require more of
physicians’ time than other chronically ill patients.
Time anticoagulant patients require:
Much less
time
%
Some-what
less time
%
About
the same
amount
of time
%
Amount of time adjusting medication
1
3
17
The amount of time I need to review
and relay their test results
-
5
The amount of time I have to spend
with the patient (both in person and
on phone/email consultations)
-
The amount of time that other staff in
my practice need to spend with the
patients
-
Somewhat
more
time
%
Much
more
time
%
Net of
more
time
%
51
28
79
26
48
22
69
6
27
53
14
67
4
34
39
22
60
Q605 Compared to your patients on other medications for other chronic conditions (such as diabetes, arthritis, chronic lung disease, heart condition, or
high blood pressure), do you find that your oral anticoagulant patients require more or less time from you or your staff for the following activities?
25
Base: Qualified Respondents (n=101)
Chart 2: More than two in five physicians report that more than
half of their patients suffered a significant life-threatening event
that precipitated treatment with blood thinning medication.
Proportion of patients that had a significant life-threatening event that
precipitated the decision to initiate therapy
<5% of patients
3%
6%
6 - 10%
20%
11 - 25%
7%
26 - 30%
12%
31 - 40%
11%
41 - 50%
12%
51 - 60%
8%
61 - 70%
13%
71 - 80%
81 - 90%
3%
91 - 100%
Q404 Proportion of patients that had a significant event
Base:
Qualified respondents (n=101)
41% of physicians say that more than half of
patients experienced a life-threatening event
5%
26
Chart 3: Majorities of physicians report that their patients experienced
problems with their anticoagulant medication, leading to doctor visits
and trips to the emergency room or hospital.
Called the office
84%
Visited the office
82%
Went to ER
52%
Went to hospital
None of these
51%
7%
Q440 In the past 12 months, have any of your patients done any of the following because of a problem related to taking their oral anticoagulant
medication?
Base:
Qualified respondents (n=101)
27
Chart 4: Physicians frequently have to make adjustments in
dosage and counsel patients about guidelines because of
problems related to their oral anticoagulant use.
Every time
%
Less than
Every
time
%
Advised/Reminded patient to follow recommended
guidelines for his/her treatment regimen (e.g.
compliance, diet, regular blood testing, etc.)
22
79
Adjusted dose of oral anticoagulant
15
86
Suggested adjustments to use of over-the-counter
medications, vitamins, or supplements the patient was
taking in addition to his/her oral anticoagulant
8
91
Made adjustments to another prescription medication
that patient was taking in addition to his/her oral
anticoagulant
4
96
Switched patient to another brand of anticoagulant
2
96
Percentage of physicians who do the following
because of patient problems related to taking oral
anticoagulants:
Q445
Thinking about all of your patients on oral anticoagulants, how often have you had to do the following because of a problem related to their oral
anticoagulant medication?
28
Base: Qualified Respondents (n=101)
Chart 5: Physicians feel that patient non-compliance with
medication regimen and recommended blood tests are the top
challenges when dealing with oral anticoagulant patients.
Percent who indicated items as one of top 3 challenges
48%
Patients not being compliant with the medication regimen
46%
Patients not getting their blood tested as directed
39%
Interactions with drugs prescribed by other physicians
30%
Patients not returning for follow-up visits
27%
Patients not following a consistent diet
26%
Patients taking OTCs that they should avoid
16%
Problems getting lab results
Problems resulting from use of generic versions
15%
Pharmacies that change the supplier of their generic versions
15%
11%
Patients not reporting symptoms or complications
Problems reaching or communicating with pharmacists about patients
None of these
4%
2%
Q610 Thinking about your experiences managing patients who take oral anticoagulants, which would you say are the biggest challenges you face?
Base: Qualified Respondents (n=101)
29
Key Finding #2: Most physicians feel that the effort to manage
multiple conditions is the main reason why oral anticoagulant
patients experience difficulties with their treatment regimen.
•
Nearly two in three physicians (61%) believe that managing
multiple health problems is the number one reason why patients
have difficulties with their anticoagulant treatment regimen.
•
Lack of patient motivation to follow recommendations is also
seen by many doctors as a key reason for problems.
•
Lack of patient information about requirements when taking an
oral anticoagulant and too little time to spend with these
patients also seen as factors.
30
Chart 6: Physicians see management of multiple conditions
and non-compliance with recommendations as the main
factors leading to patient problems.
Percent indicating items as top 1 or 2 reasons that patients experience difficulties with their regimen
These patients are trying to manage multiple
conditions and medications, in addition to their
anticoagulant
61%
Patients are not motivated to follow medication and
testing recommendations because there are no
immediate and clear rewards for treatment compliance
43%
Patients lack information about what they should or
should not do while taking an oral anticoagulant
24%
Physicians and other providers do not have enough
time to closely monitor the progress of these patients
These patients are receiving conflicting advice from
various sources
Other barriers
22%
10%
17%
Q615 What do you think are the main reasons why patients taking oral anticoagulants experience difficulties with their regimen?
Base: Qualified Respondents (n=101)
31
Key Finding #3: There is room for improvement in
communication by physicians about oral anticoagulant regimen
and blood test results.
•
•
•
•
•
•
•
Many physicians do not tell all their patients important information such as
dietary considerations and potential drug interactions when they first start
them on anticoagulant medication.
One in three physicians do not provide any of their oral anticoagulant
patients with written instructions.
While most physicians receive INR test results within 24 hours, a large
minority has to wait at least two days.
One in four physicians do not always call or mail the patients to inform them
about their INR test results.
One in five of the most commonly questions asked by patients relates to
INR results and the frequency of blood testing.
Very few physicians leave a message with the patient’s INR results, most
will wait until they have made personal contact with the patient.
When informing their patients about INR test results, many physicians do
not tell their patients the actual numeric INR value.
32
Chart 7: Many physicians do not tell their patients important information
such as dietary considerations and potential drug interactions when
they first start patients on and anticoagulant medication.
Less than
every time
%
Every time
%
Tell them about any special dietary considerations they should know
while taking this medication
44
47
Explain potential interactions between the oral anticoagulant and other
prescription or over-the-counter medications, vitamins or supplements
42
59
Explain any side effects they may experience
34
66
Tell them about symptoms to watch for and when to seek further care or
treatment
28
74
Give them specific instructions about how to take the medication
28
72
Tell them about how often they should have their blood tested
20
80
Explain why they need to take it
15
85
Advise them to wear a medical information emblem (bracelet or identifier)
or carry a piece of paper that indicates the name of their anticoagulant
medication
83
16
Issues that doctors talk about when initiating oral anticoagulant
medication for the first time:
Q402
First, please think about the situations when you start a patient on an oral anticoagulant or when you see a patient immediately after he or
she has been started on an oral anticoagulant in a hospital. In these situations, how often do you talk to your patients about the following issues when
you give them an oral anticoagulant prescription for the first time.
Base:
Qualified respondents (n=101)
*1% not sure
33
Chart 8: One in three physicians do not provide any of their
oral anticoagulant patients with written instructions.
Yes, give written
instructions to all
patients taking an
anticoagulant
Yes, give written
instructions to some
patients taking an
anticoagulant
No, do not give written
instructions
38%
31%
32%
Q407 Do you or does someone else in your office give written instructions about taking anticoagulant medications to your patients? These written
instructions may inform patients about what they should and should not do with regard to diet, concomitant prescription and over-the-counter
medication use, blood tests , etc. Please do not include the informational insert that comes with the medication or from the drug maker.
Base:
Qualified respondents (n=101)
34
Chart 9: While most physicians receive INR test results within
24 hours, a large minority has to wait at least 2 days for them.
Within 24 hours
77%
Within 48 hours
20%
Within 3 days
3%
Q420
On average, how soon after testing do you receive your patients’ INR results from the lab?
Base: Qualified respondents (n=101)
35
Chart 10: One in four physicians do not always call or mail
the patients to inform them about their INR test results.
I or someone else in my office always call patients with
INR results.
67%
I or someone in my office call patients with INR results,
but only when there is a change in the numbers.
My office always mails a letter to patients with INR
results.
My office mails a letter with INR results, but only when
there is a change in the numbers.
My office generally does not contact the patient with
INR results.
22%
5%
2%
1%
None of these describe my office’s approach to
contacting patients with INR results.
Not sure
Q425
8%
0%
Which of the following best describes your office’s general approach to contacting patients regarding their INR results?
Base: Qualified Respondents (n=101).
Note: Multiple responses question, respondents could say that they phone and send letters.
36
Chart 11: One in five of the most commonly questions asked
by patients relates to INR results and the frequency of blood
testing.
Length of time medication needs to be taken/when it can
be stopped
33%
14%
INR related, thickness of blood/too thick, too thin, OK
10%
Reason the medication need to be taken?
9%
Diet/alcohol related
Dosing related: missing/changing dosage
8%
Danger of treatment/side effects
8%
6%
Frequency of blood tests
5%
Bleeding related
6%
Other
Nothing
20%
2%
Q708 What is the most common question your oral anticoagulant patients ask you about their treatment regimen?
Base: All respondents (n=101)
37
Chart 12: Very few physicians leave a message with the
patient’s INR results, most will wait until they’ve made
personal contact with the patient.
Leave a message asking
for a return call from the
patient
46%
Continue to phone the
patient until personal
contact is made
37%
Leave a message with
the patient’s INR results
8%
Send a note to the
patient with his/her INR
results
5%
None of these
2%
Not sure
2%
Q430 If you or another health-care professional in your office cannot reach a patient personally when calling with the INR results, which of the following
38
are you most likely to do?
Base: Respondents Who Call Patients With INR Results (n=98)
Chart 13: When informing their patients about their INR test
results, many physicians do not tell their patients their
actual numeric INR value.
Tell them the actual
numeric INR value
53%
Describe the blood
characteristics (e.g.,
too thick or too thin)
31%
Describe the results in
terms of “good” or
“bad”
Other
11%
5%
Q435
What terminology do you generally use to describe INR test results to your oral anticoagulation patients?
Base: Qualified Respondents (n=101)
39
Key Finding #4: Physicians could be doing more to help
their patients with ongoing management of their oral
anticoagulant regimen.
• Nearly 2 in 5 physicians do not have a nurse or other health care
professional in their office to help patients manage their oral
anticoagulant.
• The majority of physician offices do not contact their patients every
time to remind them about their next appointment or to have their
blood tested.
40
Chart 13: Nearly 2 in 5 physicians do not have a nurse or other
health care professional in their office to help patients manage
their oral anticoagulant.
46%
Yes, a nurse
Yes, another healthcare professional
No
18%
37%
Q410 Is there a nurse or another health-care professional in your office who helps patients manage their oral anticoagulant? This may include calling
them regularly to check how well they are doing, reminding them about appointments for blood testing, reviewing their blood test results with them,
etc. Please do not include a receptionist calling the patient about appointments.
Base: Qualified respondents (n=101)
41
Chart 14: The majority of physician offices do not contact
their patients every time to remind them about their next
appointment or to have their blood tested.
Every time
%
Less than
every
time
%
Remind them of their next appointment
43
56
Remind them to have their blood tested
45
55
To check how well they are doing
21
76
Follow-up contact
Q416 How often, if ever, do you or your office staff contact your oral anticoagulant patients to….?
Base:
Qualified respondents (n=101)
42
Key Finding #5: Improving blood testing, communications and
involvement with health care professionals are seen as key components
in helping patients comply with their oral anticoagulant regimen.
•
•
•
•
Physicians report that the most effective ways to help patients
comply with their anticoagulant regimen involve improvements
in blood testing:
– Improving the speed and accuracy of blood testing
– Improving communication about blood results
Better information for patients and more assistance with
management of their treatment are also seen as solutions.
Written communication is seen by many physicians as a good
method of relaying information. Regular counseling and check
ups are also key to conveying the rules and guidelines
anticoagulant patients should follow.
Physicians trust clinic staff at anticoagulant clinics and different
doctors in their own offices the most to help in the
management of their anticoagulant patients.
Continued >
43
Chart 15a: Good communication and information are effective
in increasing patients’ compliance with oral anticoagulant
medication.
Very
Effective
%
Extremely effective
%
Net
4/5
%
29
21
50
Improving communication about blood results – consistent feedback
loop, regardless of whether INR results are good or bad
42
18
59
Better information available to patients about what they should or should
not do
33
18
50
Having more patients visit anticoagulant clinics for routine care
31
16
47
Nurses or other health-care professionals providing ongoing disease
management for patients
37
15
51
Physicians spending more time with patients to provide counseling and
support
41
11
51
Providing rewards to patients who show perfect compliance with their
medication regimen
24
11
35
Patient self-testing their blood for INR level
26
9
35
Pharmacists spending more time educating and counseling patients
26
7
33
Effective approaches:
Improve the speed and accuracy of blood testing
Q620 How effective do you think the following approaches to increasing patient oral anticoagulant compliance would be?
Base: Qualified Respondents (n=101)
44
Chart 15b: Patient self-testing and more time spent with
patients are seen as less effective approaches.
Somewhat
Effective
%
Not at all
effective
%
Net
1/2
%
Having more patients visit anticoagulant clinics for
routine monitoring
16
9
25
Providing rewards to patients who show perfect
compliance with their medication regimen
19
16
35
1
14
15
Patient self testing their blood for INR level
30
13
43
Nurses or other health-care professionals
providing ongoing disease management for
patients
6
10
16
27
9
36
13
4
17
Improving communication about blood results –
consistent feedback loop, regardless of whether
INR results are good or bad
14
3
17
Physicians spending more time with patients to
provide counseling and support
13
2
16
Effective approaches:
Better information available to patients about what
they should or should not do
Pharmacist spending more time educating and
counseling patients
Improve the speed and accuracy of blood testing
Q620 How effective do you think the following approaches to increasing patient oral anticoagulant compliance would be?
Base: Qualified Respondents (n=101)
45
Chart 16: Written communication is seen by many
physicians as a good method of relaying information.
25%
Give written guidelines/handouts
18%
Regular counseling/checkups
14%
Keep doctor informed about any changes/problems
12%
Clearly state goals/risks of taking anticoagulant
11%
Watch the diet
10%
Check with physician before taking other medications or OTCs
9%
Regular blood tests
7%
Take medication as directed
Help them understand INR test results
5%
Face-to-face communication
5%
Raise awareness of bleeding
4%
Done by hospital/clinic
4%
18%
Other
9%
Nothing
Don’t know/ not sure
3%
Q705 Please specify any particularly good methods you use or are aware of to communicate to your patients the “rules and guidelines” they should
follow because they are on an oral anticoagulant therapy.
Base: All respondents (n=101)
46
Chart 17a: Physicians trust clinic staff at anticoagulant clinics
and different doctors in their own offices the most to help in the
management of their anticoagulant patients.
Q710
Trust a
Great Deal
%
Trust
Completely
%
Net
%
Dedicated oral anticoagulation clinic staff
42
33
74
A different doctor (in my office)
41
30
70
The nurse or other health-care professional
in my office
52
20
72
My patient’s other doctors (not in my office)
38
9
47
Registered dietician
14
7
21
My patients’ pharmacists
26
6
32
Technicians at the lab
21
3
24
A paid caregiver (such as a nurse’s aid or
home-health worker)
21
2
23
An unpaid caregiver (such as a family
member of the patient)
19
1
20
How much would you trust each of the following to help your patients manage their anticoagulant regimen?
Base: All respondents (n=426)
47
Chart 17b: Physicians trust laboratory technicians the least to
help them manage their anticoagulant patients.
Q710
Trust Very
Little
%
Do Not
Trust at All
%
Net
%
Technicians at the lab
32
14
46
A paid caregiver (such as a nurse’s aid or
home-health worker)
17
9
26
Registered dietician
22
7
29
An unpaid caregiver (such as a family
member of the patient)
27
6
33
My patients’ pharmacists
20
5
25
The nurse or other health-care professional
in my office
2
2
4
My patient’s other doctors (not in my office)
11
1
12
A different doctor (in my office)
2
1
3
Dedicated oral anticoagulation clinic staff
3
-
3
How much would you trust each of the following to help your patients manage their anticoagulant regimen?
Base: All respondents (n=426)
48
Respondent Profile
49
Physician Profile
Total Number of Respondents = 101
Specialty
Family Practice (FP)
Internal Medicine (IM)
General Medicine
Cardiovascular Diseases
Geriatrics FP
Geriatrics IM
%
1
24
34
35
7
*
45
Gender
%
84
16
Male
Female
Number of Years in Practice
%
8
23
16
29
15
5
4
1
1- 5 years
6- 10 years
11- 15 years
16- 20 years
21- 25 years
26- 30 years
31- 40 years
41- 50 years
Age
20-30
31-40
41-50
51-60
61-70
70+
MEAN
%
27
27
11
11
10
15
Practice Type
Solo practice
Single-specialty partnership/group
Multi-specialty partnership/group
%
29
36
35
50